Ziad R.
- Country
- France
- Department
- Dermatology Department
Research Overview
- A Prospective Multicenter Randomized Placebo-Controlled Study of Upadacitinib in Adults with Erosive Mucosal Lichen Planus and Lichen Planopilaris
- A Phase 2 Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of LAD328 in Adults with Moderate to Severe Hidradenitis Suppurativa
- Phase 3 Extension Study of Long-Term Safety and Efficacy of Remibrutinib in Adults With Moderate to Severe Hidradenitis Suppurativa
Data & Insights
Has run more than one trial at 315 of 572 partner sites.
Specializations
Inflammatory Skin Conditions
Specializes in treating various forms of chronic inflammatory dermatological conditions, with particular focus on moderate to severe presentations.
- Atopic Dermatitis
- Plaque Psoriasis
- Hidradenitis Suppurativa
Investigates novel therapeutic approaches for persistent skin inflammation using targeted immunological treatments.
Autoimmune Conditions
Conducts research in autoimmune-mediated skin disorders with emphasis on innovative treatment modalities.
- Chronic Urticaria
- Alopecia Areata
- Vitiligo
Explores both systemic and targeted therapies for managing chronic autoimmune skin manifestations.
Therapeutic Approaches
Evaluates advanced therapeutic agents including monoclonal antibodies and small molecule inhibitors.
- Long-term Safety Studies
- Combination Therapies
- Novel Treatment Pathways
Focuses on developing treatment strategies for patients with inadequate response to conventional therapies.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.